Mo‐Li Wu
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Retinoids in leukemia and cellular processes 6
- RNA modifications and cancer 6
-
- Sirtuins and Resveratrol in Medicine 22
- Co-authors
- Qing‐You Kong (29 shared papers)Xiaohong Chen (24 shared papers)Jia Liu (14 shared papers)Xiaohong Shu (14 shared papers)Song Xue (8 shared papers)Hong Li (9 shared papers)Jia Liu (10 shared papers)Jia Liu (13 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)PLoS ONE (4 papers)Oncotarget (3 papers)Cancer Management and Research (3 papers)Journal of Neuro-Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mo‐Li Wu
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Geriatrics and Gerontology 379
- Cancer Research 230
- Oncology 298
- Molecular Medicine 49
- Genetics 101
Countries citing papers authored by Mo‐Li Wu
This map shows the geographic impact of Mo‐Li Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo‐Li Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo‐Li Wu more than expected).
Fields of papers citing papers by Mo‐Li Wu
This network shows the impact of papers produced by Mo‐Li Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo‐Li Wu. The network helps show where Mo‐Li Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mo‐Li Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 83 | |
| 2 | 2008 | 76 | |
| 3 | 2014 | 71 | |
| 4 | 2015 | 64 | |
| 5 | 2019 | 52 | |
| 6 | 2006 | 50 | |
| 7 | 2015 | 40 | |
| 8 | 2018 | 38 | |
| 9 | 2018 | 36 | |
| 10 | 2020 | 35 | |
| 11 | 2016 | 34 | |
| 12 | 2011 | 33 | |
| 13 | 2019 | 30 | |
| 14 | 2011 | 30 | |
| 15 | 2010 | 30 | |
| 16 | 2007 | 28 | |
| 17 | 2018 | 27 | |
| 18 | 2014 | 26 | |
| 19 | 2020 | 26 | |
| 20 | 2015 | 25 |
About Mo‐Li Wu
Mo‐Li Wu is a scholar working on Molecular Biology, Geriatrics and Gerontology, Oncology, Cancer Research and Epidemiology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (22 papers), Cytokine Signaling Pathways and Interactions (7 papers), Autophagy in Disease and Therapy (7 papers), Retinoids in leukemia and cellular processes (6 papers), Cancer Mechanisms and Therapy (6 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (6 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Geriatrics and Gerontology (379 citations), Cancer Research (230 citations), Oncology (298 citations), Molecular Medicine (49 citations) and Genetics (101 citations). Mo‐Li Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qing‐You Kong, Xiaohong Chen, Jia Liu, Xiaohong Shu, Song Xue, Hong Li, Jia Liu, Jia Liu, Yuan Sun and YU Li-jun. Their work appears in journals such as International Journal of Molecular Sciences, PLoS ONE, Oncotarget, Cancer Management and Research and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.